Clinical Trial Update: Opiorphin Levels in Fluids of Burning Mouth Syndrome Patients (OPIODYN) [NA]

View source ↗

Summary

A completed clinical trial (OPIODYN) investigated opiorphin levels in bodily fluids of patients with burning mouth syndrome.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Burning Mouth Syndrome

Drugs mentioned

• OPIODYN (opiorphin)

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Burning Mouth Syndrome | NA | Status: COMPLETED